ANALYSIS OF GOVERNMENT PROCUREMENTS OF MEDICINES APPLIED IN RARE DISEASES THERAPY
the article presents the results of analysis of the state procurement of the drugs for rare diseases. The analysis was conducted on the basis of 1499 selected trade procedures on rare disease drugs procurement in 2013. The article evaluates the state of competition in procurement of monopoly and alt...
Saved in:
Main Authors: | D. V. Fedyaev (Author), V. K. Fedyaeva (Author), V. V. Omelyanovsky (Author) |
---|---|
Format: | Book |
Published: |
IRBIS LLC,
2015-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
ECONOMIC JUSTIFICATION FOR TELEHEALTH TECHNOLOGY USE FOR PREVENTIVE MEDICAL EXAMINATION OF THE POPULATION IN REMOTE REGIONS
by: D. V. Fedyaev, et al.
Published: (2015) -
The concept of multi-criteria analysis of decision-making in the current system of health technology assessment in Russia
by: V. V. Omelyanovsky, et al.
Published: (2018) -
APPLICATION OF MULTIPLE-CRITERIA ANALYSIS FOR OPTIMIZATION OF FINANCING OF RARE DISEASES
by: V. V. Omelyanovskiy, et al.
Published: (2015) -
Analysis of centralized public procurement of medicines in Ukraine with the involvement of international organizations
by: V. S. Zlahoda, et al.
Published: (2022) -
Economic outcomes of centralized procurements of gene therapy for patients with orphan diseases: inherited retinal dystrophy
by: N. А. Avxentyev, et al.
Published: (2022)